All data are based on the daily closing price as of September 28, 2026
a

ASKA Pharmaceutical Holdings

4886.TSE
13.54 USD
-0.13
-0.95%

Overview

Last close
13.54 usd
Market cap
385.17M usd
52 week high
18.85 usd
52 week low
12.38 usd
Target price
15.29 usd

Valuation

P/E
11.2867
Forward P/E
N/A
Price/Sales
0.8659
Price/Book Value
0.872
Enterprise Value
423.26M usd
EV/Revenue
0.934
EV/EBITDA
6.5556

Key financials

Revenue TTM
451.52M usd
Gross Profit TTM
214.10M usd
EBITDA TTM
53.36M usd
Earnings per Share
1.22 usd
Dividend
0.38 usd
Total assets
676.07M usd
Net debt
29.08M usd

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of internal medicine, obstetrics and gynecology, and urology; and research, manufactures, imports, exports, and sells veterinary medicines and medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; engages in the manufacturing, sales, import, and distribution of prescription drugs, over-the-counter drugs, health foods, and other products; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.
  • Symbol
    4886.TSE
  • Exchange
    TSE
  • Isin
    JP3119660003
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.aska-pharma-hd.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top